Skip to main content
Watch Insiders
IDYAHealthcare

Ideaya Biosciences Inc (IDYA) Insider Trading

In the last 90 days, 1 Ideaya Biosciences Inc (IDYA) insider reported no open-market purchases and 1 sale totaling $985,397. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Oct 6, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Oct 6, 2026Yujiro S HataPresident and CEOSale26,338$37.41$985,397
Jul 7, 2026Briseno Andres RuizChief Accounting OfficerSale9,550$40.01$382,131

Common questions

IDYA insider trading FAQ

Are IDYA insiders buying or selling?
Over the last 90 days, IDYA insiders were net sellers, reporting $0.00 of open-market purchases and $985,397 of sales.
When was the last IDYA insider purchase?
No open-market insider purchase of Ideaya Biosciences Inc stock was reported in the last 90 days.
Where does IDYA insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Ideaya Biosciences Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.